41
Participants
Start Date
April 30, 2012
Primary Completion Date
August 10, 2016
Study Completion Date
December 11, 2020
Brentuximab vedotin
IV, 1.8mg/kg, every 3 weeks for 6 cycles.
ABVD
"Doxorubicin - 25mg/m2 IV over 3-5 minutes, Day 1 and 15, every 28 days, 2-6 cycles.~Bleomycin - 10u/m2 IV, Day 1 and 15, every 28 days, 2-6 cycles Vinblastine - 6mg/m2 IV over 3-5 minutes, Day 1 and 15, every 28 days, 2-6 cycles.~Dacarbazine - 375mg/m2 IV over 30 minutes, Day 1 and 15, every 28 days, 2-6 cycles."
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill
Rex Cancer Center, Raleigh
Levine Cancer Istitute, Carolinas Health Care system, Charlotte
Vanderbilt University, Nashville
Mayo Clinic, Rochester
City of Hope Comprehensive Cancer Center, Duarte
Seagen Inc.
INDUSTRY
UNC Lineberger Comprehensive Cancer Center
OTHER